Diabetes Research and Clinical Practice
Volume 77, Issue 3 , Pages 412-413 , September 2007

Early and late onset side effects of short-acting insulin analogue in seven Japanese diabetic patients

  • Akira Kuroe

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka, Japan
    • ,
  • Ataru Taniuguchi

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka, Japan
    • Corresponding Author InformationCorresponding author at: Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, 2-1-7 Fukushima, Fukushima-ku, Osaka-city, Osaka 553-0003, Japan. Fax: +81 6 6458 6994.
    • ,
  • Mitsuo Fukushima

      Affiliations

    • Department of Health Informatics Research, Japan
    • ,
  • Yoshikatsu Nakai

      Affiliations

    • Translational Research Informatics Center, Karasuma-Oike Nakai Clinic, Japan
    • ,
  • Minako Ohgushi

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka, Japan
    • ,
  • Michihiro Ohya

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka, Japan
    • ,
  • Yutaka Seino

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka, Japan

Received 17 May 2006 ,Revised 24 November 2006 ,Accepted 25 December 2006.

References 

  1. Groop LC. Sulfonylureas in NIDDM. Diab. Care. 1992;15:737–754
  2. Zinman B. Insulin regimens and strategies for IDDM. Diab. Care. 1993;16(suppl. 3):24–28
  3. Jeppesen J, Hollenbeck CB, Zhou M-Y. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity and postprandial lipemia. Arterioscler. Thromb. Vase. Biol. 1995;15:320–324
  4. Fineberg SE, Fineberg NS, Anderson JH, Birkett M, Gibson RG, Huferd S. Comparative immunogenecity of LysPro (B28, B29) human insulin analogue between type I and type II patients. Diabetologia. 1994;37(suppl.):A168
  5. Fineberg SE, Fineberg NS, Anderson JH, Birkett M. Insulin immune response to lyspro human insulin therapy in insulin naive type I and type II patients. Diabeteologia. 1995;38(suppl.):A4
  6. Buelke-Sam J, Byrd RA, Hoyt JA, Zimmerman JL. A reproductive and developmental toxicity study in CD rats of LY275585 (Lys[B28], Pro[B29]-human insulin. J. Am. Coll. Toxicol. 1994;13:247–260
  7. Mizuhashi S, Nakamura K, Mori Y, et al. Insulin allergy and immunologic insulin resistance caused by interleukin-6 in a patient with lung cancer. Diab. Care. 2006;29:1711–1712

PII: S0168-8227(07)00028-9

doi: 10.1016/j.diabres.2006.12.019

Diabetes Research and Clinical Practice
Volume 77, Issue 3 , Pages 412-413 , September 2007

Article Tools